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Abstract:  Luminescent colloidal quantum dots (QDs) possess numerous advantages as 
fluorophores in biological applications. However, a principal challenge is how to retain the 
desirable optical properties of quantum dots in aqueous media while maintaining 
biocompatibility. Because QD photophysical properties are directly related to surface 
states, it is critical to control the surface chemistry that renders QDs biocompatible while 
maintaining electronic passivation. For more than a decade, investigators have used   
diverse strategies for altering the QD surface. This review summarizes the most successful 
approaches for preparing biocompatible QDs using various chemical ligands.  
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1. Introduction  
Due to their sensitivity, reliability, and rapid response, fluorescence-based techniques are now vital 
in biological applications including in vivo and in vitro cellular targeting and imaging, molecular 
imaging, and multiplexed analyses. These applications require an appropriate fluorescent probe having 
specific chemical and optical properties. Organic and genetically-encoded fluorophores generally have 
narrow absorption, broad emission, and are vulnerable to continuous irradiation by the excitation source 
which limits their usefulness in some applications such as multiplexed measurements, long-term 
imaging, and single molecule imaging, among others [1,2]. While fluorescent dyes and proteins have 
been applied broadly to problems in biological sciences, some of their inherent weaknesses have 
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significantly limited the potential of related fluorescence techniques. Quantum dots (QDs) are appealing 
alternatives to conventional fluorophores due to their superior optical properties and have the potential 
to meet some of these outstanding challenges in biotechnology. However, the surface chemistry of 
QDs and the presence of the surface trap sites usually tend to deteriorate their properties in terms of 
quantum yield and stability. This aspect of QD synthesis remains a considerable challenge for 
researchers. In this review, we examine some of the most successful methods for rendering QDs 
biocompatible with the goal of inspiring new and related methods that realize the vast potential of 
these fluorophores. 
The physical size of colloidal QDs is usually the range of 2–15 nm in diameter where the energy 
levels of the excited state electron-hole pair (or “exciton”) are quantized rather than continuous. Within 
this nanocrystal size range, which is on the order of or smaller than the exciton Bohr radius, QDs cease 
to behave as bulk materials due to confinement of their charge carriers (electrons and holes) in three 
spatial dimensions. This endows QDs with size, shape, and composition-dependent physical/optical 
properties that are readily tunable during synthesis. Unlike conventional fluorophores, QDs have broad 
absorption spectra (QDs of multiple colors can be excited by a monochromatic source), narrow, 
symmetric, and size-tunable emission spectra (where it is relatively easy to distinguish one QD 
population from another, as shown in Figure 1); high resistance to physical and chemical degradation 
(suitable for long-term imaging); high extinction coefficients and quantum yields (sufficient for single 
molecule measurements); and long fluorescence lifetimes (on the order of 10 ns, useful in time-gated 
experiments) [2,3]. Because of their appealing and tailorable properties, they have been widely used in 
a diverse range of fields from clinical diagnostics [4-6] to photovoltaics [7,8]. 
Figure 1. Absorption and emission of six different quantum dot populations. 
 
QDs are generally synthesized using an organometallic approach in which they are stabilized by 
hydrophobic surfactants and are therefore initially soluble in non-polar media. It is critical to render 
QDs water-soluble through modification of their surface in preparation for biological applications.  
An ideal water-soluble ligand should meet the following requirements: (1) provide QDs stability and 
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solubility in biological buffers; (2) maintain a high resistance to photobleaching and other 
photophysical properties in aqueous media; (3) have functional groups which are able to conjugate to 
biomolecules; (4) minimize overall hydrodynamic size. The stability of QDs in water can be obtained 
by either a complete ligand exchange procedure, or through steric stabilization where the native 
hydrophobic surface is coated with amphiphilic molecules and/or polymers [2]. Both of these methods 
have their own advantages where the ultimate choice largely depends on the specific application and 
requirements of the nanocrystals. Small molecules carrying a net charge tend to contribute to 
aggregation in buffers of high ionic strength and exhibit variable stability with changes in pH. 
Additionally, electrostatically stabilized QDs can increase the possibility of non-specific binding in 
certain biological environments [2]. Although coating with polymers can effectively mitigate these 
problems, for example by creating a steric barrier around the nanocrystal, the effective hydrodynamic 
diameter of these QDs can increase three to four fold [9,10] which may preclude uptake into cells via 
endocytosis or disrupt signal transduction in sensing applications that utilize distance-dependent 
fluorescence resonance energy transfer (FRET). 
Here we review recent progress for preparing biocompatible QDs including aqueous phase synthetic 
methods, cap exchange procedures that completely replace hydrophobic ligands with hydrophilic 
species, encapsulating QDs with amphiphiles, and coating QDs with solid shell layers. 
2. Aqueous Synthesis of Quantum Dots 
Other than the organometallic approach, QDs can be synthesized through a more direct approach 
toward water-solubility by using phosphates [11] or thiols [12-15] acting as stabilizing agents in 
aqueous media. The ligands used during synthesis become the eventual biocompatible surface ligands 
and do not require an exchange procedure. Figure 2 illustrates a typical aqueous synthesis of CdTe [16] 
which is completed in two distinct stages. Cd and Te precursors are mixed in stage I in the presence  
of a thiol stabilizer. CdTe nanocrystals nucleate and grow by reflux in stage II. Gaponik and   
co-workers [16] investigated the effect of thiol-capping of CdTe QDs and found that each ligand has a 
unique effect on the overall performance of QDs (Table 1).  
Figure 2. Schematic of CdTe synthesis using aqueous method [16]. Copyright 2002 
American Chemical Society. 
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Table 1. Conditions for the aqueous synthesis of CdTe nanocrystals and their   
properties [16]. Copyright 2002 American Chemical Society. 
Stabilizer 
pH used for 
the synthesis 
Stability of 
CdTe QDs 
Surface charge of  
CdTe QDs 
Typical QY of  
as prepared  
CdTe QDs 
2-mercaptoethanol  11.2–11.8  stable  slightly negative in alkaline  <1% 
1-thioglycerol  11.2–11.8  stable  slightly negative in alkaline  3% 
mixture (1:1) of 1-thioglycerol 
and 2,3-dimercapto-1-propanol 
11.2–11.8  moderate  slightly negative in alkaline  6% 
thioglycolic acid (TGA)  11.2–11.8  stable  negative  10% 
2-mercaptoethylamine (MA)  5.6–5.9  moderate  positive  10% 
L-cysteine 11.2–11.8  moderate 
negative or positive 
depending on the pH 
10% 
2-(dimethylamino)ethanethiol 5.0–6.0  moderate  positive  30% 
The growth rate and surface charge of the nanocrystals depended on the choice of stabilizers. They 
had difficulty in achieving bright QDs that also exhibit long-term colloidal stability. However, the 
quantum yield (QY) of these thiol-stablized QDs can be improved by various post-synthesis treatments 
such as photochemical etching [16], long term exposure to illumination by a mercury discharge 
lamp [17] (photo annealing), and size-selective precipitation [13]. 
Glutathione (GSH), a thiol-containing tripeptide, which is known to detoxify heavy metals in plant 
cells, is able to provide improved biocompatible capping for QDs as compared with many other   
water-soluble ligands [18]. It has been used successfully to cap Au, ZnS, CdS, CdSe [19-21] and CdTe 
nanoparticles, but appears to work best with CdTe in terms of promoting high photoluminescence [22]. 
The pH of the solution containing the Cd
2+-GSH precursors and the molar ratio of Cd
2+-GSH to 
NaHTe (Te precursor) were found to have a strong influence on the QY of CdTe QDs. Higher molar 
ratios resulted in better passivation of the surface states on CdTe which led to higher QY. This effect 
saturated with complete surface passivation by Cd
2+-GSH. 
Most reported aqueous synthesis methods have focused on II-VI group nanocrystals, while there are 
few reports regarding the synthesis of III-V QDs in water, save the work of Qian’s group [23]. They 
prepared InP QDs in aqueous ammonia in the presence of potassium stearate. However, this 
hydrothermal method can only produce nanocrystals in the form of secondary particles [24].  
3. Direct Ligand Exchange 
QDs synthesized via the organometallic method require an extra processing step to achieve 
biocompatibility. The direct ligand exchange is accomplished by replacing QDs’ native hydrophobic 
ligands with hydrophilic molecules that have higher affinity for the QD surface. The most popular 
anchoring molecules utilize thiol groups. Others including amines, phosphonic acids, and carboxylic 
acids have also been widely used [25-28]. 
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3.1. Monodentate Thiols 
In 1998, Nie’s group [29] developed one of the first protocols for generating hydrophilic QDs by 
coating CdSe/ZnS core-shell QDs with mercaptoacetic acid which exploits the affinity of monothiols 
for the ZnS shell. Since then, many other monothiol ligands have been used to provide QDs   
water-solubility such as mercaptopropionic acid (MPA) [30-32], mercaptoundecanoic (MUA) [33],  
4-mercaptobenzoic acid [34], thiol-derivatized sugar [35], thiolated derivative of diethyleneglycol [36], 
dendrons [37,38], cystamine [2], cysteine [39] and related residues [40]. This approach continues to be 
a popular method due to the ease of processing and the commercial availability of candidate ligands. 
Due to the dynamic binding interactions between the thiol and ZnS, QDs coated with monothiol 
ligands tend to have shorter shelf lives [41]. Also, the pH of the solution is found to be responsible for 
the thiolate ligand stability. Peng’s group [42] used a pseudo steady-state titration method to investigate 
the stability of colloidal nanocrystals coated with thiolate ligands upon pH change. They found that as 
pH of the solution fell into a relatively low range (2–7), the thiolate ligand became protonated and 
dissociated from the nanocrystal surface. This effect was confirmed as the main reason for the 
precipitation of the nanocrystals. This dissociation process was found to be reversible and the 
equilibrium pH value was size dependent. Similarly, the luminescence QY tends to suffer with these 
samples presumably due to the instability of the ligand and reduced surface coverage over time. The 
quenching efficiency was found to depend strongly on both the size and charge of the thiol [43]. 
Several groups have found that an appropriate ligand exchange method is crucial for preserving 
colloidal stability and brightness. Pong et al. [44] discovered that the bond strength between a 
monothiol and ZnS can be increased by removing thiolic hydrogen during the adsorption process. 
Wang et al. reported [45] that the photoluminescence can be maintained if the ligand exchange step 
was eliminated as a separate step. Alternatively, they developed a new strategy, in situ shell formation 
and ligand capping, which allowed the core CdSe to be overcoated by a ZnS shell and the   
water-soluble ligand MPA in a single step. They further found the QY of synthesized CdSe/ZnS   
core-shell QDs capped with MPA was comparable to that of trioctylphosphine oxide (TOPO)-capped 
QDs while the QY of MPA-capped CdSe-ZnS QDs using ligand exchange method was five-fold lower. 
Tamang et al. [46] found that pH played an important role in increasing stability of InP/ZnS QDs 
during an aqueous phase transfer procedure. The thiol group of a water-soluble ligand is deprotonated 
at high pH, and thiolate has been shown to bind the QDs surface more strongly than thiol [47]. They 
also discovered that the QY could be improved by adding an appropriate reducing agent.  
The QD surface states have a significant effect on the quantum yield. Jeong et al. [48] found that it 
was the thiolate, not thiol, that had a time-, concentration-, and pH-dependent effect on QD surface 
states. They proved that the thiol addition could better passivate the electron trap sites and therefore 
increased the QY at low thiol concentration, while at high thiol concentration new hole traps would be 
created and QY decreased. 
A reduction in the luminescent QY mediated by thiol binding can be mitigated by either 
crosslinking or adding layers to the surface [49]. Chan’s group [50] first coated hydrophobic QDs with 
MPA and then crosslinked these ligands with lysine or diaminopimelic acid in the presence of 
dicyclohexylcarbodiimide. They later examined stability of these QDs in various biological conditions 
in order to optimize their behavior for various applications. This cost-effective, simple method was Sensors 2011, 11                  
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able to synthesize highly stable water-soluble QDs which maintained all of the hydrophobic QD 
optical properties. However, due to the relatively thick coating layer, the size was twice as big as the 
TOPO coated QDs.  
Zwitterionic monothiols, possessing positive and negative charges simultaneously, have the potential 
to minimize hydrodynamic particle size and reduce nonspecific binding. Bawendi’s group [51]   
found that zwitterionic or net neutral charged organic coatings prevented the binding of QDs to   
serum proteins. They further found that QDs having a hydrodynamic diameter below 5.5 nm can  
be efficiently removed from the body by renal clearance. They compared four different coatings 
including dihydrolipoic acid (DHLA, anionic), cysteamine (cationic), cysteine (zwitterionic), and 
DHLA-polyethylene glycol (DHLA-PEG, neutral). Of these, only cysteine and DHLA-PEG coated 
QDs were able to prevent the adsorption of serum proteins. However, the effective size of the   
DHLA-PEG coated QDs was too large to be eliminated via renal clearance. Although they showed 
promising results, the main drawback of cysteine-coated QDs was their instability. These samples 
typically precipitated after 24 hours of storage at 4 °C [39]. Breus et al. [52] used zwitterionic   
D-penicillamine (DPA) as a stabilizing ligand for QDs and showed that they are far more stable than 
cysteine-coated QDs. The chemical structures of DPA and cysteine are shown in Figure 3. These  
DPA-coated QDs were shown to be stable over a pH range of 5–9 and exhibited excellent chemical 
stability even in strongly oxidizing environments. They hypothesized that the superior stability results 
from the reduced interaction between DPA ligands. 
Figure 3. Chemical structures of (a) D-pencillamine and (b) cysteine. 
 
3.2. Bidentate Thiols 
Recognizing the poor inherent stability of monothiol-coated QDs, Mattoussi et al. [53] overcoated 
QDs with negatively charged dihydrolipoic acid (DHLA) to render them water-soluble and promote 
attachment of engineered recombinant proteins through electrostatic attraction. These QDs demonstrated 
a dramatically improved shelf life of up to two years with proper storage. Nonetheless, DHLA is not 
able to preserve the high luminescence of native QDs presumably due to its lower density on the 
nanocrystal surface. Moreover, this negatively charged capping ligand is only stable in basic 
conditions (pH ≥ 7), and may induce non-specific binding to positively charged proteins in cellular 
applications. To circumvent this, the carboxylated DHLA-coated QDs can be further modified to have 
various functional groups which can serve different purposes. As Figure 4 shows, Susumu et al. [54,55] 
developed a new class of water-soluble ligands consisting of DHLA and PEG. The appended 
functional groups (hydroxyl, carboxylic acid, amino, and biotin) are readily able to conjugate with Sensors 2011, 11                  
 
 
11042
biomolecules. In addition to DHLA [56-58] and modified DHLA [59-63], other bidentate thiols such 
as dithiothreitol (DTT) [64], and thiol-modified β-cyclodextrin [65] have been successfully used as QD 
ligands, however none of these appears capable of achieving high luminescence and small size 
simultaneously. 
Figure 4. Modular design of QD hydrophilic ligands with different terminal functional 
groups based on DHLA-PEG [55]. Copyright 2007 American Chemical Society. 
 
Liu et al. [66] recently found that the quantum yield of DHLA-coated QDs can be increased twice 
during the ligand exchange process with the presence of zinc and base. Zn(DHLA)2 formed by 
metalation of zinc and DHLA and reacted with tetradecylphosphonic acid (TDPA) which initially capped 
hydrophobic QDs. They believed that this process was able to avoid the etching of the QD shell during 
cap exchange. They compared the quantum yield of QDs capped using different methods (with or 
without zinc/base) and found that the QY was improved with the help of zinc and base (Figure 5). 
Figure 5. (a) Normalized absorption spectra of water-soluble CdSe/ZnS using different 
cap exchange methods. Inset: Emission spectra of same QDs and Rhodamine 101, excited 
at 525 nm. (b) Quantum yield of water-soluble CdSe/ZnS using different cap exchange 
methods over time. Zero quantum yield indicates the precipitation of the samples [66]. 
Copyright 2011 American Chemical Society. 
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Reiss’s group [67,68] designed a new family of ligands called carbondithioates, which have high 
resistance to photooxidation and adsorb strongly onto the QD surface. However, a new specific 
synthesis is required to prepare every new ligand. Dubois et al. [69] then developed a facile and 
effective way to prepare similar ligands called dithiocarbamates (DTCs) by simply mixing carbon 
disulfide with an appropriate amine precursor. These DTC-coated QDs lost only 15% of their initial 
fluorescence after 500 consecutive illuminations at 350 nm (having a duration of 4 s each), where their 
absorption profiles were unchanged. Similar to effects seen with other thiolated capping molecules, the 
QY of these QDs was shown to drop substantially (~40%) from its initial values. Based on similar 
chemistry, our own group [70] performed a ligand exchange procedure with DTCs in two phases rather 
than a single phase and found that the initial QY of hydrophobic QDs could be fully preserved or even 
enhanced if using high quality TOP/TOPO-capped CdSe/ZnS QDs. Another interesting finding is that 
these DTC-capped QDs can be either pH-insensitive or pH-sensitive based on the side chain group of 
the DTC ligand which may provide some advantage over traditional capping ligands. 
3.3. Multidentate Ligands 
Multidentate ligands offer QDs enhanced stability because of the increased number of binding sites 
between each ligand and the QD surface. Bawendi’s group [71] crosslinked alkyl phosphines, 
commonly used to stabilize hydrophobic QDs, with a crosslinker dissocyanatohexane to form 
polydentate ligands known as oligomeric phosphines (OPs). This new class of ligands consists of three 
components which are the inner phosphine layer (which passivate the QD surface), linking layer 
(which protect the QD), and an outer functionalized layer (which impart desirable chemical 
properties). The OPs displaying carboxylic acid groups were compared with MPA coatings on QDs 
with the former maintaining the initial QY and showing enhanced stability in various pH (ranging from 
5.5 to 12) and in high ionic strength solutions. Wang et al. [72,73] passivated QDs with a multidentate 
diblock copolymer, poly(ethylene glycol-b-2-N,N-dimethylaminoethyl methacrylate) (PEG-b-PDMA). 
The pendent tertiary amine groups had proved to high affinity to the QD surface [74]. They found that 
the QY of QDs coated with 10k and 15k molecular weight polymer prepared by traditional solution 
polymerization were substantially higher than that of QDs coated with TOPO, while the presence of 
35k molecular weight polymer synthesized by atom transfer radical polymerization (ATRP) decreased 
brightness of the QDs. They attributed this to two competing effects: enhanced surface passivation by 
the polymer and a parasitic effect caused by copper ion residual from the initiator during the ATRP 
synthesis.  
For certain biological applications, the QD capping ligands are required to minimize the nonspecific 
binding to the cell membrane or proteins. Nie’s group [75] prepared a new class of hydroxylated QDs, 
which initially have carboxyl groups, that are prepared through a hydroxylation and cross-linking 
procedure. These QDs had relatively small sizes (13–14 nm) as compared to other amphiphilic 
polymer-coated QDs (20–40 nm) [76-78]. They also evaluated their nonspecific binding properties 
with a series of different coatings including carboxylated, streptavidin-functionalized, and PEG-coated 
QDs; these results are shown in Figure 6. The hydroxylated QDs showed the lowest nonspecific 
cellular binding where a higher degree of hydroxylation helped to further reduce the nonspecific 
binding. To reduce the hydrodynamic size, they overcoated QDs with a linear polymer chain which Sensors 2011, 11                  
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had a mixed composition of thiols and amines [79]. This novel coating tightly wrapped around QD 
surface as “loops-and-trains” [73,74] where the size of QDs was as small as 4–7 nm in diameter. They 
further found that the number of available binding groups (thiols and amines) had strong influence on 
QD polydispersity, QY, and photostability. Increasing the number of binding groups offered better 
stability but sacrificed QY suggesting an optimal number of binding groups per QD.  
Figure 6. (a) Normalized photoluminescence intensity of QDs with different ligands 
measured by microplate assays. (b)  Nonspecific cellular binding of QDs with different 
degree of hydroxylation [75]. Copyright 2008 American Chemical Society. 
         
(a)                                                                 (b) 
Rather than using single DHLA as an anchoring group, Stewart et al. [80] synthesized a new set of 
multidentate PEG-based ligands which have two DHLA, or thioctic acid, molecules. These ligands 
improved QD stability to survive in conditions unfavorable to DHLA-capped QDs. They showed 
remarkably stability in various pH solutions ranging from 1.1 to 13.9 and extremely high salt 
conditions (2 M NaCl). 
4. Indirect Surface Encapsulation 
4.1. Silica Coatings 
A silica shell is another desirable method for producing biocompatible nanocrystals due to the 
formation of a contiguous protective surface layer. QDs can acquire a silica layer either through direct 
ligand exchange [81-83] (surface silanization) or indirect encapsulation [84-88] (sol-gel process, 
microemulsion, micellization of siloxane surfactants). The deposited silica shell can be further 
modified to conjugate biomolecules using standard silane coupling chemistry that is already ubiquitous 
for modifying bulk glass surfaces such as microscope slides. 
The sol-gel process was first developed by Stöber et al. [89] and requires water-soluble QDs as a 
starting material. Compared to the sol-gel process, the advantage of the microemulsion process is that 
it is able to overcoat hydrophobic QDs directly with a silica layer where the resulting nanoparticles 
have smoother surfaces and narrow size distributions [84]. Darbandi et al. [84] reported that the silica 
growth on QD surfaces involve two hypothetical mechanisms during the microemulsion process 
(Figure 7). The first possible mechanism is shown in Figure 7(a) where the surfactant forms an 
inverted bilayer around TOPO-coated QDs followed by deposition of a silica layer within the Sensors 2011, 11                  
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hydrophilic region carried out in the presence of an ammonia catalyst used to promote the 
polymerization of tetraethyl orthosilicate (TEOS). In the second hypothetical mechanism [Figure 7(b)], 
the TOPO ligand is replaced by TEOS and QDs are transferred to the aqueous phase followed by the 
polymerization of TEOS from the QD surface. The resulting nanoparticles were monodisperse and had 
high luminescence with a single QD in the center. 
Figure 7. Scheme of two hypothetical mechanisms of silica growth on QDs. (a) Silica 
growth without ligand exchange. (b)  Silica growth with ligand exchange and phase   
transfer [84]. Copyright 2005 American Chemical Society.  
 
Figure 8. Modular design of silica-coated QDs with functional groups that is readily to 
crosslink with biological molecules [83] (phosphate, PEG, or ammonium groups on the 
outer siloxane surface act as stabilizing groups to maintain water solubility). Copyright 
2002 Amercian Chemical Society.  
 
Surface silanization is another way to form a silica shell around the QD by fully displacing the  
pre-existing hydrophobic ligands. In a typical process, TOPO-coated QDs are mixed with 
mercaptopropyltrimethoxysilane (MPTS) in alkaline methanol. The mercapto group is able to bind to Sensors 2011, 11                  
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the ZnS layer of QDs and thus replace the TOPO layer, followed by heating the solution to promote 
crosslinking of the silanol groups. The silica shell is later modified to have different functional group 
such as thiols, amines, or carboxyl groups to ensure covalent attachment to biomolecules (Figure 8) [83].  
4.2. Amphiphilic Ligands 
Unlike a direct ligand exchange process where hydrophilic ligands completely replace hydrophobic 
ligands, the method of encapsulating QDs with amphiphiles uses native nonpolar molecules as binding 
intermediates. The hydrophobic section of the amphiphiles intercalates the hydrophobic stabilizing 
agent such as TOPO while the hydrophilic portion offers aqueous solubility. Surfactants such as 
phospholipids [76,90,91], α-cyclodextrin [92,93], n-alcanoic acids [94], and cetyl-trimethylammonium 
bromide [95] have all been used to transfer nanoparticles into water. However, due to relatively weak 
hydrophobic interactions, they are normally not sufficiently stable when subjected to biologically 
relevant conditions [96]. The use of amphiphilic polymers can overcome this issue because a single 
polymer chain can possess multiple hydrophobic subunits which greatly enhances intercalation affinity 
with the hydrophobic ligands on the QD surface. Yu et al. [96] prepared the amphiphilic polymer 
poly(maleic anhydride-alt-1-octadecene) (PMAO)-PEG through the reaction between PMAO and 
primary amine-terminated PEG methyl ethers. Nonpolar QDs were then mixed with PMAO-PEG in 
chloroform and stirred overnight. The modular design of these amphiphilic polymer-coated QDs is 
shown in Figure 9. These PMAO-PEG-coated QDs were found to have the same optical properties, 
including QY, as hydrophobic QDs, and successfully recognized the cancer cells with the Her2 
receptor. In this case, the binding between QDs and polymer ligands solely relies on hydrophobic 
attraction, however the length of the polymer improves this interaction substantially. The stability of 
amphiphilic polymer-coated QDs can be further improved by covalently crosslinking the outmost   
layer [78,97]. 
Figure 9. Scheme of amphiphilic polymer-coated QDs. The binding is through the 
hydrophobic attraction between the ligands that initially cap QDs and hydrophobic portion 
of the amphiphilic polymer. The outmost layer is modified with functional group for 
linking with other molecules [96]. Copyright 2007 American Chemical Society.  
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Gao’s group [98] found that capping QDs with silica and amphiphilic polymer together offered 
better passivation than capping with either one alone. Single hydrophobic CdSe/ZnS QDs were first 
incorporated into silica spheres via a reverse microemulsion, followed by surface modification with 
hydrophobic trimethoxy(octadecyl)silane (OTMS). The amiphiphilic polymer (1,2-distearoyl-sn-
glycero-3-phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000] (PE-PEG) was the attached to 
SiO2-OTMS-coated QDs through hydrophobic interactions [Figure 10(b)]. As Figure 10(a) shows, 
only QDs capped with SiO2 and PE-PEG showed similar brightness over pH 1–14. They also evaluated 
the cellular toxicity of these nanoparticles with and without embedded QDs and found that the toxicity 
is purely due to the exposure of bare nanoparticles, indicating QDs were adequately protected within 
the silica spheres with no appreciable leaching of heavy metals [Figure 10(c)]. 
Figure 10. (a) Normalized fluorescence intensity of QDs capped with different coatings 
(SiO2-PE-PEG, thiolated PEG, mercaptoacetic acid (MAA), PE-PEG, poly(maleic 
anhydride alt-1-tetradecene) (PMAT), polyethylene imine (PEI) and SiO2) in various pH 
from 1 to 14 (tuned with HCl or NaOH). The photo on the right panel shows the 
corresponding florescence image under 365 nm hand-held UV lamp. (b) Scheme of 
incorporation QDs into SiO2-PE-PEG sphere. (c) Cell viability data of SiO2-PE-PEG-coated 
QDs and SiO2-PE-PEG nanoparticles without QDs doped inside [98]. Copyright 2010 
American Chemical Society. 
  
 
 
 
 
 
 
 
 
   
(a) 
(b) 
(c) Sensors 2011, 11                  
 
 
11048
5. Conjugating Quantum Dots to Biomolecules 
To enable the use of QDs in a wider range of biological applications, all of the preceding methods 
require a route for attaching biomolecules stably onto the QD surface. A suitable ligand candidate 
should allow attachment of a diversity of biomolecules including nucleic acids, proteins 
(avidin/streptavidin, albumin, adaptor proteins, and antibodies), polysaccharides, and peptides. 
Biomolecules are commonly conjugated to the QD surface through the following approaches [99]:  
(1) covalent crosslinking: links carboxyl groups on the QD surface to amines by the use of 1-ethyl-3-
(3-dimethylaminopropl) carbodiimide (EDC) [100] or 4-(N-maleimidomethyl)-cyclohexanecarboxylic 
acid N-hydroxysuccinimide ester (SMCC) [101], which crosslinks primary amine and sulfhydryl 
groups; (2) thiolated peptides (cysteine residues) can be directly conjugated to the QD surface through 
the affinity to ZnS shell layer [102,103]; (3) adsorption or non-convalent self-assembly using 
engineered proteins (e.g., a positively charged domain, His-tags) [104-106]. Owing to the large surface 
area-to-volume ratio, several biomolecules of varying types can be attached to a single QD. Each of 
these biomolecules provides a desired function which affords multi-functionality [6]. 
6. Summary 
Biocompatible QDs are typically generated through either an organic synthetic route requiring 
subsequent ligand exchange or encapsulation, or a more direct aqueous synthetic route where the 
nanocrystals are inherently water-soluble. There are nearly countless variations of these methods 
reported in the literature where each protocol carries its own inherent advantages and disadvantages 
and must be considered in light of the eventual application. A ligand exchange procedure that uses 
small charged molecules can maintain minimal hydrodynamic diameters, but they are usually more 
susceptible to aggregation in biological buffers or solutions of high ionic strength. These compact 
capping ligands often fail to maintain suitably high luminescence without additional processing. 
Methods that improve the density of ligands on the QD surface while ensuring a strong binding 
interaction appear to have the most promise. Polymer and silica coatings are better able to isolate QDs 
from solution which results in improved colloidal stability, limited non-specific binding, and high QY. 
However, these characteristics are often achieved at the expense of compact size which can impede 
cellular mobility [107] and limit the ability to perform sensing via FRET. Although many excellent 
synthetic protocols already exist for creating biocompatible QDs, there is no ideal universal route, and 
each method must be considered against the requirements of the experiment. Continued research in this 
area is needed in order to realize the vast potential of QDs in biological applications, perhaps even 
resulting in human in vivo diagnostics and treatments. 
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